Skip to Main Content

Predicting MCI Outcome With Clinically Available MRI And CSF Biomarkers


2 mins

Study to determine the ability of clinically available volumetric MRI (vMRI) and CSF biomarkers, alone or in combination with a quantitative learning measure, to predict conversion to Alzheimer’s disease (AD) in patients with mild cognitive impairment (MCI). 2011 October 12.